T he cerebral cortex is an evolutionarily advanced brain structure made of neuronal layers tangentially organized into areas that serve higher cognitive functions. Its development commences from the formation and patterning of the neural tube, which progressively generates different classes of neurons that migrate and eventually settle into radially organized layers 1, 2 . These neurons are sequentially generated by distinct lineage-related progenitors. Upon the onset of corticogenesis, the first-born apical progenitors (APs) expand their number by symmetric division. These APs further undergo asymmetric division to give birth directly to neurons (direct neurogenesis) and later via the intermediary production of basal progenitors (indirect neurogenesis; Supplementary Fig. 1a ; reviewed in ref.
T he cerebral cortex is an evolutionarily advanced brain structure made of neuronal layers tangentially organized into areas that serve higher cognitive functions. Its development commences from the formation and patterning of the neural tube, which progressively generates different classes of neurons that migrate and eventually settle into radially organized layers 1, 2 . These neurons are sequentially generated by distinct lineage-related progenitors. Upon the onset of corticogenesis, the first-born apical progenitors (APs) expand their number by symmetric division. These APs further undergo asymmetric division to give birth directly to neurons (direct neurogenesis) and later via the intermediary production of basal progenitors (indirect neurogenesis; Supplementary Fig. 1a ; reviewed in ref. 3 ). In humans, most malformations of cortical development affect cells that contribute to the formation of the cerebral cortex during the first two trimesters of pregnancy 4, 5 . Microcephaly is a common malformation of cortical development, clinically presenting in reductions in head circumference and brain size, due to improper generation and/or survival of neurons or their progenitors. Whilst congenital microcephaly is often caused by genetic defects, environmental factors and infectious agents transmitted vertically can also lead to this phenotype 6 . Recent observations of human fetuses [7] [8] [9] , as well as experimental data obtained in animal models, strongly support the hypothesis that maternal-fetal transmission of ZIKV, a mosquito-borne virus of the Flaviviridae family, causes microcephaly 10, 11 . Furthermore, ZIKV impairs both the generation and survival of neurons deriving from ZIKV-infected cortical progenitors [12] [13] [14] [15] [16] and thus selectively interferes with developmental steps underlying cortex formation. However, the underlying molecular mechanisms of ZIKV-induced microcephaly in vivo remain poorly understood. Here we analyzed ZIKV-infected human cortical samples and mouse embryos to understand the pathophysiological mechanisms of ZIKV-induced microcephaly. We show that ZIKV triggers endoplasmic reticulum (ER) stress and an unfolded protein response (UPR) in the cerebral cortex of infected postmortem human fetuses as well as in cultured human neural stem cells. By using intracerebral or intraplacental injection of mouse embryos, we confirmed that ZIKV induces ER stress in vivo. This leads to microcephaly by deregulating a physiological UPR controlling the proper generation and survival of projection neurons during cerebral cortex development. Preventing UPR activation with pharmacological inhibitors upon ZIKV infection counteracts these pathophysiological mechanisms and prevents microcephaly in ZIKV-infected mouse embryos.
Results

ZIKV infection induces ER stress and activates UPR in human cortices and cultured neural stem cells.
We have recently demonstrated that interfering with a physiological UPR in the cortical APs leads to congenital microcephaly by altering the balance between direct and indirect neurogenesis ( Supplementary Fig. 1a ) 17 . Since ZIKV has been reported to infect APs 16, 18 and replicate in
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Articles NATure NeuroScIeNce , CHOP and PDI transcripts in occipital cortex from three control fetuses (WT; the value is normalized to 1 and corresponds to three WT at developmental ages of 21 GW, 23 GW and 24 GW) and two 22-GW fetuses infected by ZIKV during pregnancy (each histogram representing one fetus, ZIKV#1 and ZIKV#2 respectively; number of ZIKV copies per µ g of extracted RNA = 1.39 × 10 4 for ZIKV#1, RNA = 3.32 × 10 6 for ZIKV#2, average number of ZIKV copies per µ g of extracted RNA = 2.50 × 10 6 ± 1.27 × 10 6 , mean ± s.e.m.). b-f, Immunolabeling of mock-or ZIKV-infected hNSCs showing (b) Hoechst (blue), ZIKV (red) and Sox2 (green), (c,d) calnexin (green) or (e,f) calreticulin (green; n = 5 biologically independent replicates per condition). g, qRT-PCR performed on total RNA extract from mock-or ZIKV-infected hNSCs (average number of ZIKV copies per µ g of extracted RNA = 1.10 × 10 9 ± 3.28 × 10 8 , mean ± s.e.m.) to detect MX1 (**P = 0.0011, U = 0), PDI (*P = 0.05, U = 0), ATF3 (***P < 0.001, U = 0), CHAC1 (**P = 0.0011, U = 0), CHOP (**P = 0.0011, U = 0), SENS2 (***P < 0.001, U = 0), HRD1 (**P = 0.0011, U = 0) and XBP1S/U (*P = 0.05, U = 0). Data are analyzed by one-sided Mann-Whitney tests and presented as boxplots of median ± first to third quartiles; whiskers extend to maxima and minima with each symbol representing n = 3-6 biologically independent samples, as indicated on respective boxplots. Scale bars represent 25 µ m in b or 50 µ m in c−f. ***P < 0.001, **P < 0.01 and *P < 0.05.
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NATure NeuroScIeNce ER-derived structures termed viral replication factories [19] [20] [21] [22] , we hypothesized that ZIKV replication may trigger an ER stress and upregulate UPR, thereby impairing indirect neurogenesis and contributing to microcephaly. Comparison of published gene-expression profiles obtained from either ZIKV-infected brains or human cortical progenitors, as well as a genetic model of ER stress-induced microcephaly, supports the activation of UPR pathways by ZIKV ( Supplementary Fig. 1b) . Hence, we investigated whether ZIKV infection triggers microcephaly via ER stress induction by combining analyses of infected human fetal brains with data obtained in experimentally ZIKV-infected human neural stem cells (hNSCs) and embryonic mouse brains.
We performed quantitative real-time (qRT)-polymerase chain reaction (PCR) analyses of genes involved in the UPR pathways on extracted RNA from human occipital cortices of two microcephalic ZIKV-infected fetuses in the second trimester (ZIKV#1 and ZIKV#2, 22 gestational weeks or GW), and of three uninfected (wild-type, WT) fetuses of comparable gestational ages (21 GW, 23 GW, and 24 GW; Fig. 1a ). The expression of ZIKV in the brains of infected fetuses was confirmed by in situ hybridization (see representative image of ZIKV#1 in Supplementary Fig. 1c,d ). In contrast to uninfected fetuses, ZIKV-infected cortices exhibited an upregulation of the gene encoding myxovirus resistance proteins (MX1; Fig. 1a ), which is reported to be induced upon viral infection 23, 24 , as well as molecular components of the ER stress pathway and the PERK-ATF4 arm of UPR (Fig. 1a) . Together, these results suggest that ZIKV induces ER stress and triggers UPR in cortical progenitors of fetuses during pregnancy.
To experimentally test this hypothesis, we infected cultured hNSCs 25 , which display features of cortical progenitors ( Supplementary Fig. 1e ,f), with ZIKV (strain H/PF/2013) for 2 h and analyzed the ER stress and UPR molecular signatures 48 h later by qRT-PCR and immunocytochemistry (Fig. 1b-g ). We detected ZIKV RNA in infected hNSCs and observed increased immunolabeling for the ER stress markers calnexin and calreticulin 26, 27 in these cells, in contrast to most uninfected (mock) hNSCs (Fig. 1c-f) , concomitant with upregulation of MX1 and the ER stress marker protein disulfide isomerase (PDI; Fig. 1g) . Genes of the PERK-ATF4 arm of UPR were upregulated upon infection (Fig. 1g) , as seen also upon tunicamycin treatment ( Supplementary Fig. 1g ). Moreover, the increased ratio of spliced/unspliced XBP1 showed activation of the IRE-1 pathway upon ZIKV infection (Fig. 1g) . Together, these findings directly support that ZIKV triggers ER stress and UPR in hNSCs.
In vivo injection of ZIKV induces microcephaly with activation of ER stress and UPR in mice. To corroborate these findings in vivo, ZIKV particles were intracerebroventricularly (ICV) injected into the forebrains of mice at embryonic day (E) 12.5, and brains were analyzed at E18.5. Infected mouse brains were microcephalic (Fig. 2a) and were significantly lighter (Fig. 2b) , with smaller cortical dimensions (Fig. 2c) , when compared to mock-injected embryos. Similar results were obtained in newborn pups injected at E12.5 ( Supplementary Fig. 2a) . Notably, the cortical thickness of ZIKV-infected brains was significantly reduced (Fig. 2d,e) . Furthermore, ZIKV-infected brains exhibited a strong reduction of deeper neurons ( Fig. 2d; Tbr1 + or Ctip2 + neurons) and upperlayer neurons ( Fig. 2d ; Satb2 + neurons), as well as a severe disruption in their laminar organization, compared to uninfected brains (Fig. 2d) . Microdissected cortices from ZIKV-infected embryos showed an upregulation of the AP marker Pax6 but not of the intermediate progenitor (IP) marker Tbr2 (Fig. 2f) . The upregulation of Pax6 reflected the proportional increase in Pax6 + progenitors in the cortical wall upon ZIKV infection ( Supplementary Fig. 2b-d) . We also observed an overall relative reduction of expression of neuronal markers (Fig. 2f) . These findings indicate the depletion of cortical neurons. We next investigated ER stress in ZIKV-infected cortical and ZIKV-infected (n = 3) E18.5 brains (*P < 0.05, U = 0). Boxplot shows median ± first and third quartiles; whiskers extend to maxima and minima. f, qRT-PCR performed on total RNA extracts from mock-or ZIKV-infected E18.5 cortices to detect markers for APs and IPs, Pax6 (**P < 0.01, U = 0) and Tbr2 (P = 0.5714, U = 5), respectively, and the neuronal markers NeuroD6 (*P = 0. 0357, U = 0) and Tubb3 (*P = 0. 0357, U = 0). Data are analyzed by two-sided Mann-Whitney test and presented as boxplots showing median ± first to third quartiles; whiskers extend to maxima and minima, and each symbol represents n = 3-5 independent embryonic brain as indicated on respective boxplots. ****P < 0.0001, **P < 0.01, *P < 0.05; ns, not significant.
NATure NeuroScIeNce progenitors in coronal sections of E14.5 brains infected at E12.5. Congruent with our findings in ZIKV-infected hNSCs ( Fig. 1b-g ), we detected increased expression of ER stress markers in ZIKVinfected E14.5 cortices (Fig. 3a-c ). In addition, qRT-PCR analyses confirmed ER stress induction, with upregulation of Pdi in ZIKVinfected cortical extracts from E18.5 mouse embryos (Fig. 3d) . Moreover, in the same samples, we detected increased expression of key molecules of the UPR pathway, which has been shown to control the neurogenic balance in the developing mouse cortex ( Supplementary Fig. 1a ) 17 . Atf4 and its related targets (Atf5, Chac1, Chop, and Slc7a3) were significantly upregulated in ZIKV-infected cortices (Fig. 3d) , as was the ratio of spliced/unspliced Xbp1, which also suggests an activation of the IRE-1 pathway (Fig. 3d) . These data were supported by western blot analysis, which showed activation of the PERK pathway as well as a modest activation of the IRE-1 pathway ( Supplementary Fig. 2e,f) . We did not detect increased . Bottom row of a shows enlargements of the white boxed area in different channels: DAPI and ZIKV (bottom left), calnexin alone (bottom middle) and a merged image (bottom right). d, qRT-PCR performed on total RNA extracts from mock-or ZIKV-infected E18.5 cortices to detect ER stress or UPR actors, analyzed by two-sided Mann-Whitney test: PDI (*P = 0.0357, U = 0), Atf4 (*P = 0.0357, U = 0), Atf5 (*P = 0.0357, U = 0), Chac1 (*P = 0.0357, U = 0), Chop (*P = 0.0357, U = 0), Slc7a3 (*P = 0.0357, U = 0) and Xbp1S/U (*P = 0.0357, U = 0). Data presented as boxplots of median ± first to third quartiles; whiskers extend to maxima and minima and each symbol represents n = 3-5 independent embryonic brains as indicated on boxplots. e-g, Transmission electronic micrographs of E14.5 mouse cortex that were ICV-injected with either mock (n = 3) or ZIKV (n = 3) medium at E12.5, showing an unaffected AP in the mock brain (e) and affected apical progenitors in ZIKV-infected brains (f,g); red arrow indicates a ZIKV particle; n = 3 independent embryonic brains per condition). (f) AP from ZIKV-infected brain possesses an enlarged ER (red square 1) and a ZIKV particle (red square 2). (g) AP showing enlargement of the external nuclear membrane, which is continuous with the rough ER membrane system. Scale bars: 1 µ m in e-g, 500 nm in f insets, 50 µ m in b,c and 100 µ m in a (25 µ m in bottom row). We analyzed 3-5 brains per condition for all immunolabeling and histograms presented within this figure, and all embryos were taken from at least three separate litters per condition. *P < 0.05. 
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-neuron. We analyzed five E14.5 brains per condition for all immunolabeling and histograms presented within this figure, and all embryos were taken from at least three separate litters per condition. Scale bars represent 50 µ m in d and f. ***P < 0.001, **P < 0.01, *P < 0.05; ns, not significant. −/− pregnant dams infected intraperitoneally at gestational day 9.5 showed also upregulation of markers of the UPR pathway ( Supplementary Fig. 2g ). Moreover, unlike in utero mockinjected embryos (Fig. 3e) , transmission electronic micrographs of E14.5 cortical APs from ZIKV-infected embryos showed signs of ER stress (Fig. 3f,g ). Altogether, these results indicate that ZIKV infection induces ER stress and an elevation of the UPR in mouse APs in vivo.
Intracerebroventricular injection of ZIKV promotes direct neurogenesis at the expense of indirect neurogenesis in mouse.
We have previously shown that disrupting the physiological regulation of UPR in cerebral cortical APs causes microcephaly by promoting direct neurogenesis at the expense of indirect neurogenesis 17 ( Supplementary Fig. 1a ). While some projection neurons are generated from APs via direct neurogenesis, most of them arise via indirect neurogenesis, after division of IPs 28 . To test whether the deregulation of UPR induced by ZIKV infection results in the impairment of the neurogenic balance, we performed ICV injection of ZIKV in E12.5 mouse brains, followed by in utero electroporation of GFP in APs. To fate-map their direct progenies (APs, IPs, immature IPs and neurons), we assessed the expression of cell fate markers 24 h after the electroporation of GFP in APs (a time period shorter than two AP cell cycles, thereby allowing the identification of their direct progenies; Fig. 4a,b) . The phenotype of the 'direct progeny' of targeted APs was assessed by immunohistochemistry ( Fig. 4d-f Fig. 4d,f) . Analyses of ZIKV-infected GFP + APs (as detected by anti-NS1 antibodies and similarly to the anti-flavivirus group antigen, antibody 4G2; Supplementary Fig. 3a,b) showed that the majority of GFP 
Tbr2
-AP; right insets show a Tbr1 -Tbr2 + immature IP. Five E14.5 brains per condition were analyzed for all immunolabeling and histograms presented within this figure, and all embryos were taken from at least three separate litters per condition. Scale bars, 50 µ m. ****P < 0.0001, ***P < 0.001, **P < 0.01, *P < 0.05; ns, not significant. 
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ZIKV-infected cells were proliferating (65.8 ± 9.6; n = 5 brains; mean ± s.e.m.) and, compared to GFP + cells in uninfected brains, gave rise to a significantly lower proportion of IPs and a higher proportion of neurons, without reducing the fraction of self-renewing APs (Fig. 4c-e) or the rate of cell proliferation in infected cortices at E14.5 ( Supplementary Figs. 3c,d and 4a) . Altogether, these results show that in vivo infection of APs by ZIKV directly impacts cortical neurogenesis by shifting the balance toward direct neurogenesis at the expense of indirect neurogenesis, thereby reducing the overall projection neuron output. Notably, ZIKV also impairs the neurogenic balance through non-cell-autonomous mechanisms (Supplementary Fig. 4b ).
ZIKV-induced neurogenic defect is rescued by inhibition of the PERK arm of the upregulated UPR pathway in mouse.
To assess whether ZIKV directly impacts the neurogenic balance through UPR deregulation in GFP-labeled APs, we coinjected GSK2656157 (a PERK inhibitor, hereafter referred to as 'PERKi') 29 with ZIKV into the lateral ventricles of E12.5 embryos and gave a second PERKi injection at the time of electroporation (E13.5). Treatment with PERKi (10 μ M, solubilized in dimethyl sulfoxide, DMSO) did not perturb the neurogenic balance, as no significant differences were detected in different cellular compartments between brains treated with mock + DMSO and those treated with mock + PERKi. Moreover, administration of DMSO did not change the ability of ZIKV (ZIKV + DMSO) to impair neurogenesis as compared to control (mock + DMSO; Fig. 5a-d ). Coadministering PERKi with ZIKV corrected the imbalance between direct and indirect neurogenesis, rescuing the proportions of APs, newborn IPs, IPs and neurons to control levels at E14.5, when compared to mock + DMSO and mock + PERKi treatment (Fig. 5a-d and Supplementary Fig. 4b ). Altogether, these data suggest that proper cortical neurogenesis can be restored in the context of ZIKV infection by chemically reducing the activation of UPR induced by ZIKV-associated ER stress.
In vivo inoculation of ZIKV, but not related flaviviruses, induces microcephaly and apoptosis in mouse brains. Although an increase of UPR can also lead to apoptosis 30 , we did not observe a reduction of cell survival at E14.5 ( Supplementary Fig. 4c ) and only detected significant neuronal apoptosis later at E18.5 in ZIKV brains infected at E12.5 ( Fig. 6a and Supplementary Fig. 4d ), concomitant with elevated PDI expression ( Supplementary Fig. 4e ). While detailed analysis revealed that only a fraction of ZIKV-expressing neurons was apoptotic (Fig. 6b) , no significant apoptosis was observed in the progenitor region of the cortex, likely because ZIKV favors the generation of neurons that exit this region (Fig. 4c,e) 
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. Indeed, most dying cells were observed in the postmitotic regions of the cortex (Fig. 6b) , and a single injection of 50 μ M PERKi at the time of infection (E12.5) decreased ER stress ( Supplementary Fig. 4f,g ) and apoptosis (Fig. 6b) . Strikingly, injection of PERKi reduced ZIKV-induced microcephaly (Fig. 6c) , as supported by the significant improvement of brain weight, cortical dimensions and number of neurons in different cortical layers ( Supplementary Fig. 5a ,b) compared to vehicle treatment. Since increased splicing of Xbp1 was also detected in ZIKV-infected hNSCs and mouse brains (Figs. 1g and 3d) , we also injected an inhibitor of IRE-1, 4μ 8 C (IRE-1i) . This rescued the microcephaly phenotype to a similar extent compared to PERKi (Fig. 6c) . IRE-1i also prevented activation of the PERK-ATF4 UPR arm (Supplementary Fig. 4h ), suggesting a potential crosstalk between the two UPR pathways 31, 32 . While PERKi displays no antiviral effect on ZIKV, as it is not associated with a reduction of the number of cortical cells infected by ZIKV (Supplementary Fig. 4i ) or the number of ZIKV particles detected in extracts from cortical samples ( Supplementary Fig. 4j) , the IRE-1i-mediated rescue may also partly result from impaired ZIKV replication ( Supplementary   Fig. 4j ). Our data thus suggest that the predominant mechanism of ZIKV-induced microcephaly is the impairment of a physiological UPR that controls the balance between direct and indirect neurogenesis and whose disruption reduces the neuronal output as well as long-term neuronal survival.
To model the natural ZIKV infection pathway 11 , we injected viral particles into the placenta of NMRI mice at E12.5 33 . Similarly to ICV infection (Fig. 2d,e) , E12.5 intraplacental injection of ZIKV led to reduction of cortical thickness at E18.5, together with ER stress induction ( Supplementary Fig. 5c ), massive neuronal apoptosis (Fig. 6b) and impairment of cortical cytoarchitecture (Fig. 6e) . These ZIKV-induced cortical defects were rescued by coinjection of PERKi.
To investigate whether the tropism for APs and the capability to cross the embryonic blood-brain barrier is unique to ZIKV, we intraplacentally injected either the neurotropic strain of yellow fever virus 10 (vaccine strain 17D or YFV17D) or West Nile virus (WNV), two closely related flaviviruses. Although all three flaviviruses efficiently infected the placental tissue (Fig. 6h) , YFV17D and WNV neither infected APs, triggered apoptosis nor induced microcephaly (Fig. 6f-i) . Of note, YFV17D exhibits a tropism for cells in the intermediate zone and cortical plate, which are predominantly postmitotic neurons (Fig. 6g) .
Discussion
The formation of the cerebral cortex involves successive waves of neurons whose generation is finely regulated. At the onset of corticogenesis, neurons are predominantly born directly via asymmetric division of APs. Later, APs produce IPs, which further divide symmetrically to generate the bulk of projection neurons via a process termed indirect neurogenesis. The neurogenesis balance (direct versus indirect) is dynamically regulated during development by a physiological UPR whose disruption leads to microcephaly 17 . ZIKV, which has been recently associated with microcephaly in humans 8, 9 , targets cortical APs in vivo 12, 13, 15, 18 . Our study showed ER stress and UPR activation both in postmortem cortical samples from ZIKV-infected human fetuses and in cultured human neural stem cells. Furthermore, our in vivo experiments in mouse embryos demonstrated vertical transmission of ZIKV and confirmed its selective targeting of cortical APs. In stark contrast to previous studies reporting apoptotic death of neural progenitors in vitro 15, 34 , we did not observe apoptosis of ZIKV-infected APs. Moreover, infection of APs did not interfere with their proliferation but rather with their ability to generate IPs, hence leading to reduced neuronal output in the infected developing cortex.
Additionally, the neurogenic defect was also detected in noninfected ZIKV APs, either due to a non-cell-autonomous mechanism or suggesting that the level of infection was below the threshold of immunodetection. Notably, these defects were rescued by inhibition of PERK in ZIKV-positive and ZIKV-negative cortical cells.
Infected neurons rapidly exit the progenitor regions to invade the cortical plate, a process that may also involve the destabilization of adherens junction complexes by ZIKV-encoded nonstructural proteins 35 . The sustained ER stress in infected projection neurons subsequently triggers terminal UPR and apoptosis via upregulation of Chop in vivo ( Supplementary Fig. 5d-f) . Altogether, our data indicates that ZIKV-induced ER stress and UPR deregulation contribute to microcephaly via reduced neuronal output from APs and by enhancing susceptibility of their neuronal progeny to terminal UPR-dependent apoptosis (Supplementary Fig. 5g ).
UPR is mediated by three pathways, and we demonstrated that direct inhibition of the PERK-mediated UPR pathway in ZIKVinfected brains rescues the neurogenic balance and prevents terminal UPR-induced apoptosis, thereby preventing microcephaly. Furthermore, inhibition of the IRE-1a-mediated UPR also rescued ZIKV-induced microcephaly in mouse embryos. Inhibiting IRE-1a reduces ZIKV replication, but also downregulates Atf4,
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We report that infection by ZIKV, but not YFV17D or WNV, contributes to microcephaly via a specific cascade of events: (i) vertical transmission of virus, (ii) targeting of APs and (iii) induction of ER stress and activation of UPR in APs and neurons. The infection of mouse organotypic cultures by WNV has suggested its possible tropism for cortical cells 36 . However, using intraplacental injection of WNV, we show that it did not cross the embryonic blood-brain barrier to reach the developing cortex in vivo. We conclude that targeting UPR activation by inhibitors stands as a potential therapeutic approach aimed at lowering ZIKV-associated neuropathogenesis in the developing cortex.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41593-017-0038-4. 162c (genome pos. 1,162-1,139 ): 5′ -CCACTAACGTTCTTTTGCAGACAT-3′ . This standard curve allows the conversion of Cp of samples queried for Zika virus (as described above) into N° of Zika copies/µ L. We used the following formula to link this quantification to the amount of RNA retrotranscribed for the analysis of each sample:
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where k is a correction factor introduced to calculate the N° of copies with respect to 1 µ g of RNA (in this instance 0.5 µ g of RNA were used to synthetize cDNA, so k = 2), d is a dilution factor, taking into account the dilution of cDNA used for the analysis (in this case the cDNA was diluted 1:30, so d = 30) and P is a correction factor introduced to calculate the N° of Zika copies with respect to the total amount of cDNA (here 3.4 µ L on a total of 20 µ L of cDNA mix were used, so P = 5.88). Finally, the N° of copies/µ g RNA was divided for the relative concentration of each sample analyzed by qRT-PCR (since for each analyzed gene in this study we performed a relative quantification compared to the controls of the same experiment). The relative concentration of each sample is automatically calculated by the LightCycler480 and its accompanying software.
Transmission electron microscopy. Human fetal cortical samples and E14.5 mouse brains were fixed at 4 °C, for 24 and 2 h respectively, in 2.5% glutaraldehyde in 0.1 M Sörensen's buffer (0.2 M NaH 2 PO 4 , 0.2 M Na 2 HPO 4 , pH 7.4) for 2 h. Human fetal cortical samples were fixed at 4 °C in the same solution for 24 h. After several washes in Sörensen's buffer, the mouse and human samples were postfixed at 4 °C with 2% osmium tetroxide in Sörensen's buffer for 60 min, then washed in deionized water, dehydrated at room temperature through a graded ethanol series (70, 96 and 100%) and embedded in Epon for 48 h at 60 °C. Ultrathin 70-nm sections were obtained by means of an ultramicrotome (Reichert Ultracut E) equipped with a diamond knife (Diatome). The sections were mounted on copper grids coated with collodion and contrasted with uranyl acetate and lead citrate for 15 min each.
Image acquisition and manipulation. For immunofluorescent images of embryonic brain and hNSCs sample, magnified fields (20 × , 40 × and 60 ×) were acquired with either the Nikon A1 or the Zeiss LSM 880 AiryScan Elyra S.1 confocal microscopes and further processed with ImageJ 1.42q 276 (Wayne Rasband, National Institutes of Health) and Fiji (version 2.0.0-rc-54/1.51 h, https://imagej.net/Fiji) software. Fluorescence levels of Pax6 were divided by corresponding DAPI fluorescence levels, followed by normalization to that of Mock group and expressed as arbitrary units. ZIKV immunofluorescence levels were quantified as ROIs (50 μ m × 50 μ m) in the cortical wall and divided for corresponding DAPI fluorescence levels. Values were normalized to those of the ZIKV DMSO group and expressed as arbitrary units. The ultrathin transmission electron microscopy sections were observed under a JEM-1400 transmission electron microscope (Jeol) at 80 kV and photographed with an 11 megapixel bottom-mounted TEM camera system (Quemesa, Olympus). The images were analyzed via RADIUS software (Olympus, version 2.0).
Protein extraction and western blot.
Proteins for western blot analysis were extracted from E15.5 mouse brains injected at E12.5 with either simple culture medium (mock) or Zika virus. Once collected, the brains were stored in Trizol (Ambion-Life Technologies, 15596018) at -80 °C before use. RNA and proteins were consecutively extracted from the same samples according to the Trizol manufacturer's protocol. Extracted proteins were finally resuspended in a solution of 0.5% SDS/4 M urea and quantified by NanoDrop 1000 (Nano-Drop Technologies). Proteins (20 µ g) were mixed with loading buffer four times (200 mM Tris-Cl pH 6.8, 4% β -mercaptoethanol, 8% SDS, 0.4% bromophenol blue, 40% glycerol), incubated for 5 min at 95 °C, separated by SDS-PAGE and blotted on a nitrocellulose membrane (Hybond ECL, GE Healthcare Life Science). The following antibodies were used to detect UPR factors: rabbit anti-PERK (1/500, #3192, Cell Signaling), rabbit anti-p-PERK (Thr 980; 1/500, #3179, Cell Signaling), rabbit anti-eIF2α (D7D3) XP (1/500, #5324, Cell Signaling), rabbit anti-phospho-eif2α (Ser51; D9G8; XP; 1/500, #3398, Cell Signaling), rabbit anti-IRE1α (14C10; 1/500, #3294, Cell signaling), anti-phospho-IRE1α (S724; 1/500, Abcam, ab48187) and Atf6 (1/100, #65880, Cell Signaling). To enhance the detection of specific bands, the membrane was incubated for 10 min in antigen pretreatment solution (Supersignal Western Blot Enhancer kit, Thermo Scientific) and then for 1 h in 3% BSA / TBS Tw 0.1%. Primary antibodies were diluted in primary antibody diluent (Supersignal Western Blot Enhancer kit, Thermo Scientific) and the incubation with the membrane lasted 2 h at RT. Primary antibodies were detected by the use of an HRP-conjugated anti-rabbit antibody (1/10,000, RPN4301, GE Healthcare) and the membranes were developed with Pierce-ECL Western Blotting Substrate (Thermo Scientific). Images of membranes were taken by ImageQuant LAS 4000 (GE Healthcare Life Science; see Supplementary Fig. 6 ).
Experimental design and randomization. No statistical methods were used to predetermine sample sizes, but our sample sizes are similar to and based on those reported in previous publications of neurogenic balance during cortical development 15, 17, 42 . Cultured hNSCs in 6-and 24-well plates were randomly allocated to either the mock or ZIKV infections. All time-mated pregnant dams and embryos were randomly allocated to the different treatments during the surgeries. Each replicate in all animal studies herewithin was considered as one individual mock-treated or viral-infected embryo.
Statistical analysis. Single blinding was performed, whereby information regarding treatment of each sample was not transferred between the animal surgeon, the microscopist and analyst until the final data were acquired for statistical analyses. GraphPad Prism software (version 6.02) was used for the analyses, where statistical tests were applied according to the distribution, variance and normality of each dataset. As specified in the figure legends, all dual comparisons were performed using either unpaired two-tailed Student's t tests for parametric datasets or one-or two-sided Mann-Whitney tests for nonparametric datasets. Additionally, multiple comparisons were performed with one-or two-way ANOVA followed by Bonferroni post hoc tests for parametric datasets and with Kruskal-Wallis followed by Dunn's post hoc tests for nonparametric datasets, as specified in the figure legends. Levels of significance: ****P < 0.0001, ***P < 0.001, **P < 0.01, *P < 0.05 for all statistics herein; and ns means not significant. The number of biological replicates in each experiment is specified in the figure legends. No samples were excluded from analyses. 
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Materials and reagents
Policy information about availability of materials
Materials availability
Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a for-profit company.
There are neither restrictions on availability of unique materials, nor for distribution by a for-profit company. No common misidentified cell lines were used.
Animals and human research participants
Policy information about studies involving animals; when reporting animal research, follow the ARRIVE guidelines
Description of research animals
Provide details on animals and/or animal-derived materials used in the study.
Time-mated immunocompetent NMRI (Janvier Labs, Saint Berthevin, France) were operated on either embryonic day E12.5 to E14.5. Time-mated IFN-α/βR−/− mice were operated on at embryonic day E9.5 (See Supplementary Information > Material and Methods > Animals, and Supplementary Information > Material and Methods > Intracerebroventricular (ICV) and intraperitoneal (IPL) ZIKV injection, and in utero electroporation).
